.. Comme-marqueur-diagnostique-de-scs, 62 b. Comme marqueur d'une atteinte vasculaire, p.63

M. Elhai, C. Meune, and J. Avouac, Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies, Rheumatology, vol.51, issue.6, pp.1017-1043, 2012.
DOI : 10.1093/rheumatology/ker269

J. Pope, D. Shum, and R. Gottschalk, Increased pigmentation in scleroderma, J Rheumatol, vol.23, pp.1912-1918, 1996.

F. Van-den-hoogen, D. Khanna, and J. Fransen, 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative, Annals of the Rheumatic Diseases, vol.62, issue.(Suppl), pp.2737-2784, 2013.
DOI : 10.1002/art.27580

A. Smith, G. Holti, and S. Shuster, Immunoreactive beta-melanocyte-stimulating hormone and melanin pigmentation in systemic sclerosis., BMJ, vol.2, issue.6038, pp.733-737, 1976.
DOI : 10.1136/bmj.2.6038.733-a

URL : http://static.www.bmj.com/content/bmj/2/6038/733.2.full.pdf

T. Yamamoto, Y. Sawada, and I. Katayama, Local expression and systemic release of stem cell factor in systemic sclerosis with diffuse hyperpigmentation, British Journal of Dermatology, vol.33, issue.1, pp.199-200, 2001.
DOI : 10.1016/0190-9622(95)91274-6

R. Vancheeswaran, T. Magoulas, and G. Efrat, Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction?, J Rheumatol, vol.21, pp.1838-1882, 1994.

K. Yamane, T. Miyauchi, and N. Suzuki, Significance of plasma endothelin-1 levels in patients with systemic sclerosis, J Rheumatol, vol.19, pp.1566-71, 1992.

T. Kadono, K. Kikuchi, and S. Sato, Elevated plasma endothelin levels in systemic sclerosis, Archives of Dermatological Research, vol.39, issue.5, pp.439-481, 1995.
DOI : 10.1007/BF00373425

H. Tabata, N. Hara, and S. Otsuka, Correlation between diffuse pigmentation and keratinocyte-derived endothelin-1 in systemic sclerosis, International Journal of Dermatology, vol.3, issue.12, pp.899-902, 2000.
DOI : 10.1136/bmj.2.6038.733-a

D. Abraham, T. Krieg, and J. Distler, Overview of pathogenesis of systemic sclerosis, Rheumatology, vol.48, issue.suppl_3, pp.3-7, 2009.
DOI : 10.1093/rheumatology/ken481

U. Walker, A. Tyndall, and L. Czirják, Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database, Annals of the Rheumatic Diseases, vol.66, issue.6, pp.754-63, 2007.
DOI : 10.1136/ard.2006.062901

U. A. Walker, Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database, Annals of the Rheumatic Diseases, vol.66, issue.6
DOI : 10.1136/ard.2006.062901

S. Dolni?ar, A. Rotar, Z. Tomsi?, and M. , Incidence of scleroderma spectrum disorders in Slovenia, Clin. Exp. Rheumatol, vol.31, pp.8-11, 2013.

M. C. Arias-nuñez, Systemic Sclerosis in Northwestern Spain, Medicine, vol.87, issue.5, pp.272-280, 2008.
DOI : 10.1097/MD.0b013e318189372f

L. Guern and V. , Prevalence of systemic sclerosis in a French multi-ethnic county, Rheumatology, vol.43, issue.9, pp.1129-1137, 2004.
DOI : 10.1093/rheumatology/keh253

D. Cirstéa, F. Guillemin, J. Virion, and J. De-korwin, Nouvelles donn??es sur la pr??valence de la scl??rodermie syst??mique en France, La Revue de M??decine Interne, vol.30, p.74, 2009.
DOI : 10.1016/j.revmed.2009.03.128

T. J. Laing, Racial differences in scleroderma among women in Michigan, Arthritis & Rheumatism, vol.110, issue.4, pp.734-742, 1997.
DOI : 10.1161/01.CIR.21.6.1088

URL : http://onlinelibrary.wiley.com/doi/10.1002/art.1780400421/pdf

A. C. Gelber, Race and Association With Disease Manifestations and Mortality in Scleroderma, Medicine, vol.92, issue.4, pp.191-205, 2013.
DOI : 10.1097/MD.0b013e31829be125

URL : http://pdfs.journals.lww.com/md-journal/2013/07000/Race_and_Association_With_Disease_Manifestations.1.pdf?token=method|ExpireAbsolute;source|Journals;ttl|1504238919418;payload|mY8D3u1TCCsNvP5E421JYK6N6XICDamxByyYpaNzk7FKjTaa1Yz22MivkHZqjGP4kdS2v0J76WGAnHACH69s21Csk0OpQi3YbjEMdSoz2UhVybFqQxA7lKwSUlA502zQZr96TQRwhVlocEp/sJ586aVbcBFlltKNKo+tbuMfL73hiPqJliudqs17cHeLcLbV/CqjlP3IO0jGHlHQtJWcICDdAyGJMnpi6RlbEJaRheGeh5z5uvqz3FLHgPKVXJzddFRrD2hcIwdDP9eSnSkfs2/GTuiz1vf54CNU1ZiHpkg=;hash|HzIOlSMX9WvyhEhftRQw/g==

V. Steen, R. T. Domsic, M. Lucas, N. Fertig, and T. A. Medsger, A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis, Arthritis & Rheumatism, vol.13, issue.Suppl, pp.2986-2994, 2012.
DOI : 10.1097/RHU.0b013e318124a89e

F. C. Arnett, Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts, Arthritis & Rheumatism, vol.38, issue.6, pp.1359-1362, 2001.
DOI : 10.1002/art.1780381219

URL : http://onlinelibrary.wiley.com/doi/10.1002/1529-0131(200106)44:6<1359::AID-ART228>3.0.CO;2-S/pdf

Y. Allanore, Physiopathologie de la sclérodermie systémique. médecine/sciences 32, pp.183-191, 2016.

E. C. Leroy, Scleroderma (systemic sclerosis): classification, subsets and pathogenesis, J. Rheumatol, vol.15, pp.202-205, 1988.

E. C. Leroy and T. A. Medsger, Criteria for the classification of early systemic sclerosis, J. Rheumatol, vol.28, pp.1573-1576, 2001.

F. Van-den-hoogen, 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative, Annals of the Rheumatic Diseases, vol.62, issue.(Suppl), pp.2737-2747, 2013.
DOI : 10.1002/art.27580

M. Elhai, C. Meune, J. Avouac, A. Kahan, and Y. Allanore, Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies, Rheumatology, vol.51, issue.6, pp.1017-1026, 2012.
DOI : 10.1093/rheumatology/ker269

A. J. Tyndall, Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database, Annals of the Rheumatic Diseases, vol.69, issue.10, pp.1809-1815, 2010.
DOI : 10.1136/ard.2009.114264

C. Ferri, Systemic Sclerosis, Medicine, vol.81, issue.2, pp.139-153, 2002.
DOI : 10.1097/00005792-200203000-00004

L. Scussel-lonzetti, Predicting Mortality in Systemic Sclerosis, Medicine, vol.81, issue.2, pp.154-167, 2002.
DOI : 10.1097/00005792-200203000-00005

P. D. Sampaio-barros, Survival, Causes of Death, and Prognostic Factors in Systemic Sclerosis: Analysis of 947 Brazilian Patients, The Journal of Rheumatology, vol.39, issue.10, pp.1971-1978, 2012.
DOI : 10.3899/jrheum.111582

J. Avouac, Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group, Annals of the Rheumatic Diseases, vol.70, issue.3, pp.476-481, 2011.
DOI : 10.1136/ard.2010.136929

M. Cutolo, A. Sulli, C. Pizzorni, and S. Accardo, Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis, J. Rheumatol, vol.27, pp.155-160, 2000.

F. Ingegnoli, I. Ardoino, P. Boracchi, M. &. Cutolo, and . Eustar, Nailfold capillaroscopy in systemic sclerosis: Data from the EULAR scleroderma trials and research (EUSTAR) database, Microvascular Research, vol.89, pp.122-128, 2013.
DOI : 10.1016/j.mvr.2013.06.003

P. J. Clements, Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: High-dose versus low-dose penicillamine trial, Arthritis & Rheumatism, vol.78, issue.11, pp.2445-2454, 2000.
DOI : 10.1093/biomet/78.3.691

S. Zhang, Telangiectasia as a potential clinical marker of microvascular lesions in systemic sclerosis patients from EUSTAR data in China, Clin. Exp. Rheumatol, vol.33, pp.106-110, 2015.

C. Hurabielle, Skin Telangiectasia and the Identification of a Subset of Systemic Sclerosis Patients With Severe Vascular Disease, Arthritis Care & Research, vol.33, issue.Suppl 91, pp.1021-1027, 2016.
DOI : 10.1002/art.24394

V. Steen, C. P. Denton, J. E. Pope, and M. Matucci-cerinic, Digital ulcers: overt vascular disease in systemic sclerosis, Rheumatology, vol.48, issue.suppl_3, pp.19-24, 2009.
DOI : 10.1093/rheumatology/kep105

URL : https://academic.oup.com/rheumatology/article-pdf/48/suppl_3/iii19/18096586/kep105.pdf

E. Hachulla, Natural history of ischemic digital ulcers in systemic sclerosis: singlecenter retrospective longitudinal study, J. Rheumatol, vol.34, pp.2423-2430, 2007.

J. H. Korn, Digital ulcers in systemic sclerosis: Prevention by treatment with bosentan, an oral endothelin receptor antagonist, Arthritis & Rheumatism, vol.132, issue.12, pp.3985-3993, 2004.
DOI : 10.7326/0003-4819-132-6-200003210-00002

M. Matucci-cerinic, Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind

C. Bruni, Digital ulcers as a sentinel sign for early internal organ involvement in very early systemic sclerosis, Rheumatology, vol.54, issue.1, pp.72-76, 2015.
DOI : 10.1093/rheumatology/keu296

C. Mihai, Digital ulcers predict a worse disease course in patients with systemic sclerosis, Annals of the Rheumatic Diseases, vol.70, issue.(Suppl 2), pp.681-686, 2016.
DOI : 10.1136/ard.2010.132431

E. Rosato, Intrarenal Hemodynamic Parameters Correlate with Glomerular Filtration Rate and Digital Microvascular Damage in Patients with Systemic Sclerosis, Seminars in Arthritis and Rheumatism, vol.41, issue.6, pp.815-821, 2012.
DOI : 10.1016/j.semarthrit.2011.11.005

E. Rosato, Increased Intrarenal Arterial Stiffness May Predict the Occurrence of New Digital Ulcers in Systemic Sclerosis, Arthritis Care & Research, vol.39, issue.Suppl 7, pp.1380-1385, 2014.
DOI : 10.1002/art.1780390622

F. Bartoli, Calcinosis in systemic sclerosis: subsets, distribution and complications, Rheumatology, vol.55, issue.9, pp.1610-1614, 2016.
DOI : 10.1093/rheumatology/kew193

N. Galiè, Guidelines for the diagnosis and treatment of pulmonary hypertension, ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT), pp.2493-2537, 2009.
DOI : 10.1016/j.repce.2011.10.006

J. Avouac, Prevalence of Pulmonary Hypertension in Systemic Sclerosis in European Caucasians and Metaanalysis of 5 Studies, The Journal of Rheumatology, vol.37, issue.11, pp.2290-2298, 2010.
DOI : 10.3899/jrheum.100245

N. Galiè, Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial, The Lancet, vol.371, issue.9630, pp.2093-2100, 2008.
DOI : 10.1016/S0140-6736(08)60919-8

D. Khanna, Recommendations for Screening and Detection of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension, Arthritis & Rheumatism, vol.64, issue.12, pp.3194-3201, 2013.
DOI : 10.1002/acr.21641

V. D. Steen, Kidney involvement in systemic sclerosis Presse Medicale Paris Fr, pp.305-314, 1983.
DOI : 10.1016/j.lpm.2014.02.031

E. Savarino, Gastrointestinal motility disorder assessment in systemic sclerosis, Rheumatology, vol.52, issue.6, pp.1095-1100, 2013.
DOI : 10.1093/rheumatology/kes429

URL : https://academic.oup.com/rheumatology/article-pdf/52/6/1095/5201236/kes429.pdf

Y. Allanore and A. Kahan, Heart involvement in systemic sclerosis]. Presse Medicale Paris Fr, pp.1938-1942, 1983.

Y. Allanore, Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis, Annals of the Rheumatic Diseases, vol.69, issue.01, pp.218-221, 2010.
DOI : 10.1136/ard.2008.103382

C. Ferri, M. Emdin, H. Nielsen, and P. Bruhlmann, Assessment of heart involvement, Clin. Exp. Rheumatol, vol.21, pp.24-28, 2003.

K. B. Morrisroe, M. Nikpour, and S. M. Proudman, Musculoskeletal Manifestations of Systemic Sclerosis, Rheumatic Disease Clinics of North America, vol.41, issue.3, pp.507-518, 2015.
DOI : 10.1016/j.rdc.2015.04.011

J. Avouac, P. J. Clements, D. Khanna, D. E. Furst, and Y. Allanore, Articular involvement in systemic sclerosis, Rheumatology, vol.51, issue.8, pp.1347-1356, 2012.
DOI : 10.1093/rheumatology/kes041

URL : https://academic.oup.com/rheumatology/article-pdf/51/8/1347/5212440/kes041.pdf

F. M. Meier, Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database, Annals of the Rheumatic Diseases, vol.71, issue.8, pp.1355-1360, 2012.
DOI : 10.1136/annrheumdis-2011-200742

J. J. Paik, Myopathy in scleroderma and in other connective tissue diseases, Current Opinion in Rheumatology, vol.28, issue.6, pp.631-635, 2016.
DOI : 10.1097/BOR.0000000000000336

D. L. Tuffanelli and R. K. Winkelmann, Systemic Scleroderma, Archives of Dermatology, vol.84, issue.3, pp.359-371, 1961.
DOI : 10.1001/archderm.1961.01580150005001

V. K. Sharma, T. Trilokraj, B. K. Khaitan, and S. M. Krishna, Profile of systemic sclerosis in a tertiary care center in North India, Indian Journal of Dermatology, Venereology and Leprology, vol.72, issue.6, pp.416-420, 2006.
DOI : 10.4103/0378-6323.29336

J. D. Reveille, Systemic sclerosis in 3 US ethnic groups: A comparison of clinical, sociodemographic, serologic, and immunogenetic determinants, Seminars in Arthritis and Rheumatism, vol.30, issue.5, pp.332-346, 2001.
DOI : 10.1053/sarh.2001.20268

S. W. Osler, On diffuse scleroderma: with special reference to diagnosis, and to the use of the thyroid-gland extract, J Cutan Dis, vol.16, p.49, 1898.

J. L. Sánchez, M. Vázquez, and N. P. Sánchez, Vitiligolike Macules in Systemic Scleroderma, Archives of Dermatology, vol.119, issue.2, pp.129-133, 1983.
DOI : 10.1001/archderm.1983.01650260037013

O. O. Adelowo and S. Oguntona, Scleroderma (systemic sclerosis) among Nigerians, Clinical Rheumatology, vol.22, issue.4, pp.1121-1125, 2009.
DOI : 10.1016/S0025-6196(12)60294-8

K. K. Solanki, C. Hor, W. S. Chang, C. Frampton, and D. H. White, Clinical utility of hypo- and hyperpigmentation of skin in diffuse cutaneous systemic sclerosis, International Journal of Rheumatic Diseases, vol.71, issue.11, pp.767-773, 2017.
DOI : 10.1136/annrheumdis-2011-200742

N. Fujimoto, Y. Hamaguchi, and T. Tanaka, Vitiligo-like depigmentation with perifollicular pigment retention in systemic sclerosis treated successfully with suplatast tosilate, Eur. J. Dermatol. EJD, vol.26, pp.110-112, 2016.

A. G. Smith, G. S. Holti, and S. Shuster, Immunoreactive beta-melanocyte-stimulating hormone and melanin pigmentation in systemic sclerosis., BMJ, vol.2, issue.6038, pp.733-734, 1976.
DOI : 10.1136/bmj.2.6038.733-a

URL : http://static.www.bmj.com/content/bmj/2/6038/733.2.full.pdf

J. E. Pope, D. T. Shum, R. Gottschalk, A. Stevens, and R. Mcmanus, Increased pigmentation in scleroderma, J. Rheumatol, vol.23, pp.1912-1916, 1996.

J. C. Jawitz, M. K. Albert, T. P. Nigra, and R. D. Bunning, A new skin manifestation of progressive systemic sclerosis, Journal of the American Academy of Dermatology, vol.11, issue.2, pp.265-268, 1984.
DOI : 10.1016/S0190-9622(84)70163-0

S. Sukenik, A. Kleiner-baumgarten, and J. Horowitz, Hyperpigmentation along tendons in progressive systemic sclerosis, J. Rheumatol, vol.13, pp.474-475, 1986.

S. Sukenik, D. Buskila, and A. Kleiner-baumgarten, Hyperpigmentation of the skin along the thoracic and lumbar spine in progressive systemic sclerosis, J. Rheumatol, vol.18, pp.1946-1947, 1991.

A. G. Fam and P. Lee, The belt sign in scleroderma, J. Rheumatol, vol.17, pp.725-726, 1990.

A. S. Darrigade, Pigmented skin patches without scleroderma as a predominant clinical symptom revealing systemic sclerosis, Clinical and Experimental Dermatology, vol.76, issue.4, pp.379-382, 2016.
DOI : 10.1111/j.1365-3083.2012.02757.x

M. Chuamanochan, A. L. Haws, and P. Pattanaprichakul, Reticulate hyperpigmentation in systemic sclerosis: a case report and review of the literature, Journal of Medical Case Reports, vol.23, issue.1, p.219, 2015.
DOI : 10.1046/j.1365-2133.2001.03983.x

H. L. Ee and S. H. Tan, Reticulate hyperpigmented scleroderma: a new pigmentary manifestation, Clinical and Experimental Dermatology, vol.39, issue.2, pp.131-133, 2005.
DOI : 10.1001/archderm.119.2.129

R. Vancheeswaran, Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction?, J. Rheumatol, vol.21, pp.1838-1844, 1994.

K. Yamane, Significance of plasma endothelin-1 levels in patients with systemic sclerosis, J. Rheumatol, vol.19, pp.1566-1571, 1992.

T. Kadono, Elevated plasma endothelin levels in systemic sclerosis, Archives of Dermatological Research, vol.39, issue.5, pp.439-442, 1995.
DOI : 10.1007/BF00373425

D. J. Abraham, T. Krieg, J. Distler, and O. Distler, Overview of pathogenesis of systemic sclerosis, Rheumatology, vol.48, issue.suppl_3, pp.3-7, 2009.
DOI : 10.1093/rheumatology/ken481

Y. Mostmans, The role of endothelial cells in the vasculopathy of systemic sclerosis: A systematic review, Autoimmunity Reviews, vol.16, issue.8, 2017.
DOI : 10.1016/j.autrev.2017.05.024

H. Tabata, Correlation between diffuse pigmentation and keratinocyte-derived endothelin-1 in systemic sclerosis, International Journal of Dermatology, vol.3, issue.12, pp.899-902, 2000.
DOI : 10.1136/bmj.2.6038.733-a

T. Yamamoto, Y. Sawada, I. Katayama, and K. Nishioka, Local expression and systemic release of stem cell factor in systemic sclerosis with diffuse hyperpigmentation, British Journal of Dermatology, vol.33, issue.1, pp.199-200, 2001.
DOI : 10.1016/0190-9622(95)91274-6